![](/wp-content/uploads/2022/07/July-19-2022-Blast-Cover.png)
$599
Novartis and J&J Q2 ’22 Earnings Updates
Two cardiometabolic-related news items have been observed: Novartis (press release; slides) and J&J (press release; slides) hosted their respective Q2 ’22 earnings calls. Below, FENIX provides highlights and insights for the respective new items.